scholarly journals Role of cardiopulmonary exercise testing in idiopathic dilated cardiomyopathy

2013 ◽  
Vol 34 (suppl 1) ◽  
pp. P2979-P2979
Author(s):  
A. Iorio ◽  
A. Di Lenarda ◽  
E. Zambon ◽  
E. Berton ◽  
M. Merlo ◽  
...  
Keyword(s):  
Dilated Cardiomyopathy ◽  
Exercise Testing ◽  
Cardiopulmonary Exercise Testing ◽  
Idiopathic Dilated Cardiomyopathy ◽  
Cardiopulmonary Exercise

Prognostic value of cardiopulmonary exercise testing in Idiopathic Dilated Cardiomyopathy

2016 ◽  
Vol 223 ◽  
pp. 596-603 ◽  
Author(s):  
Gianfranco Sinagra ◽  
Annamaria Iorio ◽  
Marco Merlo ◽  
Antonio Cannatà ◽  
Davide Stolfo ◽  
...  
Keyword(s):  
Dilated Cardiomyopathy ◽  
Exercise Testing ◽  
Prognostic Value ◽  
Cardiopulmonary Exercise Testing ◽  
Idiopathic Dilated Cardiomyopathy ◽  
Cardiopulmonary Exercise

Cardiopulmonary Exercise Testing in Children With Heart Failure Secondary to Idiopathic Dilated Cardiomyopathy

CHEST Journal ◽  
2001 ◽  
Vol 120 (3) ◽  
pp. 816-824 ◽  
Author(s):  
Guilherme Veiga Guimarães ◽  
Giovanni Bellotti ◽  
Amilcar Oshiro Mocelin ◽  
Paulo Roberto Camargo ◽  
Edimar Alcides Bocchi
Keyword(s):  
Heart Failure ◽  
Dilated Cardiomyopathy ◽  
Exercise Testing ◽  
Cardiopulmonary Exercise Testing ◽  
Idiopathic Dilated Cardiomyopathy ◽  
Cardiopulmonary Exercise

Risk stratification in hf with mid-range LVEF: the role of cardiopulmonary exercise testing

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
B.M.L Rocha ◽  
G.J Lopes Da Cunha ◽  
P.M.D Lopes ◽  
P.N Freitas ◽  
F Gama ◽  
...  
Keyword(s):  
Risk Stratification ◽  
Exercise Testing ◽  
Primary Endpoint ◽  
Prognostic Significance ◽  
Cardiopulmonary Exercise Testing ◽  
Left Ventricular ◽  
Left Ventricular Ejection ◽  
Ventricular Ejection Fraction ◽  
Cardiopulmonary Exercise

Abstract Background Cardiopulmonary exercise testing (CPET) is recommended in the evaluation of selected patients with Heart Failure (HF). Notwithstanding, its prognostic significance has mainly been ascertained in those with left ventricular ejection fraction (LVEF) <40% (i.e., HFrEF). The main goal of our study was to assess the role of CPET in risk stratification of HF with mid-range (40–49%) LVEF (i.e., HFmrEF) compared to HFrEF. Methods We conducted a single-center retrospective study of consecutive patients with HF and LVEF <50% who underwent CPET from 2003–2018. The primary composite endpoint of death, heart transplant or HF hospitalization was assessed. Results Overall, 404 HF patients (mean age 57±11 years, 78.2% male, 55.4% ischemic HF) were included, of whom 321 (79.5%) had HFrEF and 83 (20.5%) HFmrEF. Compared to the former, those with HFmrEF had a significantly higher mean peak oxygen uptake (pVO2) (20.2±6.1 vs 16.1±5.0 mL/kg/min; p<0.001), lower median minute ventilation/carbon dioxide production (VE/VCO2) [35.0 (IQR: 29.1–41.2) vs 39.0 (IQR: 32.0–47.0); p=0.002) and fewer patients with exercise oscillatory ventilation (EOV) (22.0 vs 46.3%; p<0.001). Over a median follow-up of 28.7 (IQR: 13.0–92.3) months, 117 (28.9%) patients died, 53 (13.1%) underwent heart transplantation, and 134 (33.2%) had at least one HF hospitalization. In both HFmrEF and HFrEF, pVO2 <12 mL/kg/min, VE/VCO2 >35 and EOV identified patients at higher risk for events (all p<0.05). In Cox regression multivariate analysis, pVO2 was predictive of the primary endpoint in both HFmrEF and HFrEF (HR per +1 mL/kg/min: 0.81; CI: 0.72–0.92; p=0.001; and HR per +1 mL/kg/min: 0.92; CI: 0.87–0.97; p=0.004), as was EOV (HR: 4.79; CI: 1.41–16.39; p=0.012; and HR: 2.15; CI: 1.51–3.07; p<0.001). VE/VCO2, on the other hand, was predictive of events in HFrEF but not in HFmrEF (HR per unit: 1.03; CI: 1.02–1.05; p<0.001; and HR per unit: 0.99; CI: 0.95–1.03; p=0.512, respectively). ROC curve analysis demonstrated that a pVO2 >16.7 and >15.8 mL/kg/min more accurately identified patients at lower risk for the primary endpoint (NPV: 91.2 and 60.5% for HFmrEF and HFrEF, respectively; both p<0.001). Conclusions CPET is a useful tool in HFmrEF. Both pVO2 and EOV independently predicted the primary endpoint in HFmrEF and HFrEF, contrasting with VE/VCO2, which remained predictive only in latter group. Our findings strengthen the prognostic role of CPET in HF with either reduced or mid-range LVEF. Funding Acknowledgement Type of funding source: None

scholarly journals Pulmonary Capillary Hemangiomatosis: The Role of Invasive Cardiopulmonary Exercise Testing

2015 ◽  
Vol 5 (3) ◽  
pp. 580-586 ◽  
Author(s):  
Hilary M. DuBrock ◽  
Richard L. Kradin ◽  
Josanna M. Rodriguez-Lopez ◽  
Richard N. Channick
Keyword(s):  
Exercise Testing ◽  
Cardiopulmonary Exercise Testing ◽  
Cardiopulmonary Exercise ◽  
Pulmonary Capillary ◽  
Pulmonary Capillary Hemangiomatosis
Sign in / Sign up

Export Citation Format

Share Document